Peer
Reviewer
Name† |
Representation |
Research
Grant |
Speakers
Bureau/
Honoraria |
Stock
Ownership |
Consultant/Advisory
Board |
Dr.
John W. Hirshfeld, Jr. |
Official
Reviewer –
ACCF Board of Trustees |
None |
None |
None |
None |
Dr.
W. Barton Campbell |
Official
Reviewer –
ACCF Board of Governors |
None |
None |
None |
None |
Dr.
Joseph S. Alpert |
Official
Reviewer –
ACC/AHA Task Force
on Practice Guidelines |
None |
None |
None |
None |
Dr.
Scott Grundy |
Official
Reviewer – AHA |
Abbott
Laboratories
Astra Zeneca
Bristol-Myers Squibb
GlaxoSmithKline
Kos Pharmaceuticals
McNeil Pharmaceuticals
Merck
Pfizer
Veterans Affairs |
Abbott
Laboratories
Astra Zeneca
Bristol-Myers Squibb
Cooper Aerobics Center
Kos Pharmaceuticals
McNeil Pharmaceuticals
Merck
Pfizer
Tularik, Inc. |
None |
None |
Dr.
L. Kristin Newby |
Official
Reviewer – AHA;
AHA Committee on Acute
Cardiac Care |
Bristol-Myers
Squibb
Dade-Behring
Millennium
Novartis
Roche Diagnostics
Roche Pharmaceuticals
Sanofi
Schering-Plough
Research Institute |
Biosite
Bristol-Myers Squibb-
Sanofi
Ischemia Technologies
Institute |
None |
None |
Dr.
E. Magnus Ohman |
Official
Reviewer – AHA;
AHA Committee on Acute
Cardiac Care |
Aventis
Berlex
Bristol-Myers Squibb
Merck
Millennium
Pfizer
Sanofi |
None |
Medtronic |
None |
Dr.
Deborah Allen |
Organizational
Reviewer –
American Academy of
Family Physicians |
Merck
Aventis
Cor/Millennium
Guidant
Lilly |
None |
None |
None |
Dr.
Peter Bogaty |
Organizational
Reviewer –
Canadian Cardiovascular
Society |
Merck
Pfizer |
Abbott
Laboratories |
Merck |
None |
Dr.
Jennifer Adgey |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
Jeffrey Anderson |
Content
Reviewer –
ACC/AHA Task Force
on Practice Guidelines |
None |
Johnson
& Johnson/Merck
Merck
Merck/Schering Plough |
None |
Alteon
Merck
Johnson &
Johnson/Merck |
Dr.
Jean Barbey |
Content
Reviewer –
Pharmacological Review |
None |
None |
None |
None |
Dr.
Eugene Braunwald |
Content
Reviewer –
ACC/AHA 2002 Guideline
Update for Management
Unstable Angina |
None |
None |
None |
None |
|
Dr.
Robert Califf |
Content
Reviewer –
ACC/AHA 2002 Guideline
Update for Management of
Unstable Angina |
Accumetrics
Actelion
Ajinomoto
Alsius
Amgen
Astra Hassle
Aventis
Biomarin
Biosite
Boston Scientific
Bracco
Bristol-Myers Squibb
Cambridge Heart
Cardiodynamics
Centocor
Chase Medical
Chiron
Coagulation Diagnostics
Corcept
Corgentech
Critline
Dade Behring
Daiichi
Datascope
Devco
Elan Pharmaceuticals
Enzon
Esai
Geneceutics
Genentech
GlaxoSmithKline
Guidant
Guilford Pharmaceuticals
Harvard Health Care
Hemosol
InfraReDx
Intracel
IOMED
Lincare
Medicure
Medivance
Medtronic Foundation
Merck
Millennium
NABI
Novartis
Ortho Biotech
Otsuka
Parke Davis
Pfizer
Pharmacia/Upjohn
Pheromone Science
Proctor and Gamble
Promethesus
Quanam
Salix
Sanofi
Spectranetics
St. Jude Medical
Synaptic
The Medicines Company
Theravance
Vesicor
Vicuron
Wyeth Ayerst
Yamanouchi |
Aventis
Bristol-Myers Squibb
Conceptis
GlaxoSmithKline
Merck
Millennium
Novartis
Ortho Biotech
Paraxel
Pennside Partners
Pfizer
Pharmacia/Upjohn
Pharsight
Schering Plough
Wyeth Ayerst |
None |
GlaxoSmithKline
Pfizer |
Dr.
Kanu Chatterjee |
Content
Reviewer –
ACC/AHA 2002 Guideline
Update for Management of
Chronic Stable Angina |
None |
Astra
Zeneca
CV Therapeutics
Bristol-Myers Squibb
Merck
Novartis
Pfizer |
None |
None |
Dr.
James Cleeman |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
Stephen Ellis |
Content
Reviewer –
ACCF Clinical Data Standards
for Acute Coronary Syndromes |
Medtronic |
None |
None |
Cordis
Guidant
Boston Scientific |
Dr.
Nathan Every |
Content
Reviewer –
ACCF Clinical Data Standards
for Acute Coronary Syndromes |
Genentech |
None |
None |
None |
Dr.
Daniel Fintel |
Content
Reviewer –
Individual Review |
None |
Merck
Aventis
Sanofi |
None |
None |
Dr.
Valentin Fuster |
Content
Reviewer –
ACC/AHA Task Force on
Practice Guidelines |
Cordis
GlaxoSmithKline
Schering AG |
None |
None |
GlaxoSmithKline |
Dr.
Bernard Gersh |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
Raymond Gibbons |
Content
Reviewer –
ACCF Cardiovascular Imaging
Committee |
Alsius
Corp
Boehringer Ingelheim (pending)
Boston Scientific (pending)
Innercool Therapies
King Pharm
Medtronic
Radiant Medical
Ther Ox
Wyeth-Ayerst |
None |
None |
Boehringer
Ingelheim
Biostream (pending)
CV Therapeutics
DOV Pharmaceuticals
GlaxoSmithKline
Hawaii Biotech
King Pharm
Medicure |
Dr.
W. Brian Gibler |
Content
Reviewer –
AHA Committee on
Cardiac Care |
Bristol-Myers
Squibb
Acute Millennium/Schering Plough |
None |
None |
None |
Dr.
A. Daniel Glassman |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
Gabriel Gregoratos |
Content
Reviewer –
ACC/AHA Task Force on
Practice Guidelines |
None |
None |
None |
GlaxoSmithKline |
Dr.
Cindy Grines |
Content
Reviewer –
Individual Review |
Amersham
Health
Aventis
Berlex
Eli-Lilly
Esperion Therapeutics
GlaxoSmithKline
Guidant
Innercool Therapies
Johnson & Johnson
Otsuka
Pfizer
SCIMED |
None |
None |
Aventis
Innercool Therapies
Guidant
The Medicines Company
Pfizer |
Dr.
Timothy Henry |
Content
Reviewer –
ACCF Emergency Cardiac
Care Committee |
Anges
Aventis
BMS
Berlex
Boston Scientific
Cordis
Genentech
Genzyme
Medicines Company
Medtronic
Millennium |
None |
None |
None |
Dr.
L. David Hillis |
Content
Reviewer –
ACC/AHA Guidelines
Update for Coronary Artery
Bypass Graft Surgery (in progress) |
None |
None |
None |
None |
Dr.
Loren Hiratzka |
Content
Reviewer –
ACC/AHA Task Force on
Practice Guidelines |
None |
None |
None |
None |
Dr.
David Holmes |
Content
Reviewer –
ACCF Clinical Competence
Statement on Interventional
Training Procedures |
None |
None |
None |
None |
Dr.
Alan Jaffe |
Content
Reviewer –
Individual Review |
Beckman-Coulter
Dade-Behring
Roche |
None |
None |
Abbott
Laboratories
Aventis
Beckman
Dade-Behring
Diadexus
Ortho
Pfizer
Roche
Sensera |
Dr.
Desmond Julian |
Content
Reviewer –
Individual Review |
None |
None |
None |
AstraZeneca
Aventis
Eli Lilly
GlaxoSmithKline
Merck
Novartis
Pfizer
Servier |
Dr.
Carlos Kase |
Content
Reviewer –
Neurological Review |
None |
None |
None |
None |
Dr.
Dean Kereiakes |
Content
Reviewer –
ACC/AHA 2002 Guideline
Update for Management
Unstable Angina |
None |
None |
None |
None |
Dr.
J. Ward Kennedy |
Content
Reviewer –
ACC/AHA/SCAI Guideline
Update for Percutaneous
Coronary Intervention
(in progress) |
None |
None |
None |
None |
Dr.
Peter Libby |
Content
Reviewer –
ACCF Peripheral Vascular Disease
Committee |
Astra
Zeneca
Bayer
Bristol-Myers Squibb
Merck
Novartis
Pfizer
Sankyo
SmithKline Beecham |
Astra
Zeneca
Bayer
Bristol-Myers Squibb
Merck
Novartis
Pfizer |
None |
Astra
Zeneca
Avant Immunotherapeutics
Bayer
Bristol-Myers Squibb
Interleukin Genetics
Merck
Millennium
Novartis
Pfizer
Pierre Fabre
Sankyo
Sanofi
Schering-Plough
SmithKline Beecham
Volcano Therapeutics |
Dr.
A. Michael Lincoff |
Content
Reviewer –
Individual Review |
Eli
Lilly
Centocor
The Medicines Company |
None |
None |
None |
Dr.
Kathleen McCauley |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
George McKendall |
Content
Reviewer –
ACCF Board of Governors
ACCF Cardiac Catheterization
and Intervention Committee |
None |
None |
None |
None |
Dr.
Richard Pasternak |
Content
Reviewer –
ACC/AHA 2002 Guideline
Update for Management of Chronic
Stable Angina |
None |
Bristol-Myers
Squibb/Sanofi
Merck
Merck/Schering-Plough
Kos
Pfizer |
None |
Astra
Zeneca
Bristol-Myers
Squibb/Sanofi
Johnson & Johnson-Merck
Kos
Merck
Pfizer Health Solutions |
Dr.
Marc Pfeffer |
Content
Reviewer –
ACCF Hypertensive Diseases
Committee |
Astra
Zeneca
Aventis
Bristol-Myers Squibb
Genzyme
Mitsubishi Pharma Corp
Novartis
Pfizer |
Astra
Zeneca
Aventis
Bristol-Myers Squibb
Genzyme
Mitsubishi Pharma Corp
Novartis
Pfizer |
None |
Ortho
Biotech |
Dr.
Charles Pollack |
Content
Reviewer –
Individual Review |
Aventis
Sanofi |
Aventis
Bristol-Myers Squibb
Key ACS
Millennium
Scios |
None |
Aventis
Key ACS |
Dr.
Barbara Riegel |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
Rose Marie Robertson |
Content
Reviewer –
Individual Review |
None |
None |
None |
Merck
(spouse) |
Dr.
Richard Russell |
Content
Reviewer –
ACC/AHA/ASNC 2003
Guideline Update for
Radionuclide Imaging |
None |
None |
None |
None |
Dr.
Thomas Ryan |
Content
Reviewer –
ACC/AHA Guidelines for
Management of Patients with
Acute Myocardial Infarction |
None |
None |
Abbott
Labs
Amgen
Cardinal Health Care
King Pharm |
GenVec |
Dr.
Cathy A Sila |
Content
Reviewer –
Neurological Review |
None |
None |
None |
Centocor
Paion
Bristol-Myers/Sanofi
Squibb |
Dr.
Burton Sobel |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
John Stratton |
Content
Reviewer –
Individual Review |
None |
None |
None |
None |
Dr.
Frans Van de Werf |
Content
Reviewer –
ACCF Clinical Data Standards
for Acute Coronary Syndromes |
Aventis
Boehringer Ingelheim
Genentech
Menarini
Novartis
Servier |
Aventis
Boehringer Ingelheim
Genentech
Menarini
Novartis
Servier |
None |
Aventis
Boehringer Ingelheim
Genentech
Menarini
Novartis
Servier |
Dr.
Nanette Wenger |
Content
Reviewer –
Individual Review |
Astra
Zeneca
Bristol-Myers Squibb
Eli Lilly |
Aventis
Bristol-Myers Squibb
Eli Lilly
Merck
Pfizer
Wyeth-Ayerst |
None |
Aventis
Bristol-Myers Squibb
Merck
Pfizer
Women First Healthcare, Inc. |
Dr.
Harvey White |
Content
Reviewer –
Individual Review |
None |
None |
None |
The
Medicines Company |
Dr.
Clyde Yancy |
Content
Reviewer –
ACC/AHA Guideline
Update for Heart Failure
(in progress) |
None |
Scios |
None |
GlaxoSmithKline |